Share the post "Gujarat Terce Laboratories : Q4 2024 Financial Quarterly Report : YoY Sales Down 5.29 %, QoQ Down 6.24 %"
Highlights
- Sales over the Year and quarter: The company’s sales declined by -5.29 % over the year, decrease in net sales/revenue by -6.24 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -20 %, Marginal increase in other income during this quarter, up by 0%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Gujarat Terce Laboratories Ltd. Profit dropped by -32.25 % Year to Year, Gujarat Terce Laboratories Ltd’s profitability dropped by -19.17 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -32.41 % Year to Year. EPS decreased by -19.78 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 12.889 Cr | Rs. 13.02 Cr | Rs. 12.207 Cr | -6.24 % | -5.29 % |
| Expenses | Rs. 13.08 Cr | Rs. 12.18 Cr | Rs. 11.2 Cr | -8.05 % | -14.37 % |
| Operating Profit | Rs. -0.19 Cr | Rs. 0.84 Cr | Rs. 1.01 Cr | + 20.24 % | + 631.58 % |
| OPM % | -1.47 % | 6.45 % | 8.27 % | + 1.82 % | + 9.74 % |
| Other Income | Rs. 0.1 Cr | Rs. 0.08 Cr | Rs. 0.08 Cr | + 0 % | -20 % |
| Interest | Rs. 0.17 Cr | Rs. 0.16 Cr | Rs. 0.15 Cr | -6.25 % | -11.76 % |
| Depreciation | Rs. 0.16 Cr | Rs. 0.09 Cr | Rs. 0.09 Cr | + 0 % | -43.75 % |
| Profit before tax | Rs. -0.42 Cr | Rs. 0.67 Cr | Rs. 0.85 Cr | + 26.87 % | + 302.38 % |
| Tax % | -291.65 % | 0 % | 35.66 % | + 35.66 % | + 327.31 % |
| Net Profit | Rs. 0.8 Cr | Rs. 0.67 Cr | Rs. 0.54 Cr | -19.4 % | -32.5 % |
| EPS in Rs | Rs. 1.08 | Rs. 0.91 | Rs. 0.73 | -19.78 % | -32.41 % |
Today, we’re looking at Gujarat Terce Laboratories Ltd’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -5.29 %. However, it did see a marginal slip of -6.24 % from the previous quarter. Expenses decreased slightly by -8.05 % quarter-on-quarter, aligning with the annual decline of -14.37 %. Operating profit, while up 631.58 % compared to last year, faced a quarter-on-quarter increase of 20.24 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 9.74 %, but an expansion of 1.82 % sequentially. Other income rose by 0 % compared to the last quarter, despite an annual decline of -20 %. Interest expenses dropped significantly by -6.25 % from the previous quarter, yet the year-over-year decrease remains at a moderate -11.76 %. Depreciation costs climbed by 0 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -43.75 %. Profit before tax grew annually by 302.38 % but saw an increase from the preceding quarter by 26.87 %.
Tax expenses as a percentage of profits increased slightly by 327.31 % compared to last year, with a more notable quarter-on-quarter increase of 35.66 %. Net profit fell by -32.5 % year-on-year but witnessed a -19.4 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -32.41 % but a quarterly fall of -19.78 %. In summary, Gujarat Terce Laboratories Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 12.889 Cr | Rs. 13.02 Cr | Rs. 12.207 Cr | -6.24 % | -5.29 % |
| Expenses | Rs. 13.08 Cr | Rs. 12.18 Cr | Rs. 11.2 Cr | -8.05 % | -14.37 % |
| Operating Profit | Rs. -0.19 Cr | Rs. 0.84 Cr | Rs. 1.01 Cr | + 20.24 % | + 631.58 % |
| Net Profit | Rs. 0.8 Cr | Rs. 0.67 Cr | Rs. 0.54 Cr | -19.4 % | -32.5 % |
| EPS in Rs | Rs. 1.08 | Rs. 0.91 | Rs. 0.73 | -19.78 % | -32.41 % |
In reviewing Gujarat Terce Laboratories Ltd’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -5.29 % year-on-year, although there was a slight dip of -6.24 % from the previous quarter. Expenses decreased by -14.37 % compared to the previous year, with a decrease of -8.05 % quarter-on-quarter. Operating Profit surged by 631.58 % annually, and saw a 20.24 % increase from the last quarter.
Net Profit showed yearly decrease of -32.5 %, and experienced a -19.4 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -32.41 % annually, however dipped by -19.78 % compared to the last quarter. In essence, while Gujarat Terce Laboratories Ltd exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
